In today’s recent session, 5,441,962 shares of the AstraZeneca PLC(NASDAQ:AZN) have been traded, and its beta is 0.56. Most recently the company’s share price was $48.93, and it changed around -$0.29 or -0.01% from the last close, which brings the market valuation of the company to $129.59 Billion. AZN at last check was trading at a discount to its 52-week high of $64.94, offering almost -32.72% off that amount. The share price’s 52-week low was $42.84, which indicates that the recent value has risen by an impressive 12.45% since then. We note from AstraZeneca PLC’s average daily trading volume that its 10-day average is 7.1 Million shares, with the 3-month average coming to 11.07 Million.
AstraZeneca PLC stock received a consensus recommendation rating of Buy, based on a mean score of 1.2. If we narrow it down even further, the data shows that 1 out of 25 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended AZN as a Hold, whereas 21 deemed it a Buy, and no one rated it as Underweight. AstraZeneca PLC is expected to report earnings per share of $0 for the current quarter.
AstraZeneca PLC (NASDAQ:AZN): Trading Information Today
Although AZN has been showing red trend so far today with a performance of -0.59% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $50.13 on Wednesday, Mar 31 increased the stock’s daily price by 2.29%. The company’s shares are currently down -0.02% year-to-date, but still down -0.0198 over the last five days. On the other hand, AstraZeneca PLC (NASDAQ:AZN) is 0.02% up in the 30-day period. We can see from the shorts that 94.94 Million shares have been sold at a short interest cover period of 8.58 day(s).
The consensus price target as assigned by Wall Street analysts is $64.21, which translates to bears needing to increase their stock price by 31.23% from its current value. Analyst projections state that AZN is forecast to be at a low of $47.24 and a high of $83.12. In order for the stock price to hit the forecast high, the stock would need to surge +69.88% from its current level, while the stock would need to crash -3.45% from its current level to reach the projected low.
AstraZeneca PLC (AZN) projections and forecasts
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of $7.22 Billion in revenue for the current quarter. 2 analysts expect AstraZeneca PLC to make $7.52 Billion in revenue for the quarter ending June 01, 2021. The company’s sales for the same quarters a year ago were $6.35 Billion and $6.28 Billion respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 13.7%. Forecasts for the next quarter put sales growth at 19.9%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 1.7%. AstraZeneca PLC earnings are expected to increase by 137.2% in 2021, but the outlook is positive 19.5% per year for the next five years.
AZN Dividend Yield
The annual dividend yield of the stock is 2.84 percent and its annual dividend per share was $1.4. It is important to note, however, that the 2.84% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision. The average dividend yield for the past five years averaged 3.7% per year.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
AstraZeneca PLC (NASDAQ:AZN)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 0% of AstraZeneca PLC shares, and 15.67% of them are in the hands of institutional investors. The stock currently has a share float of 15.67%. AstraZeneca PLC stock is held by 907 institutions, with Primecap Management Company being the largest institutional investor. By Dec 30, 2020, it held 1.91% of the shares, which is about 50.11 Million shares worth $2.5 Billion.
Wellington Management Group, LLP, with 1.85% or 48.59 Million shares worth $2.43 Billion as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Vanguard/Primecap Fund and Washington Mutual Investors Fund were the top two Mutual Funds as of Dec 30, 2020. The former held 27042568 shares worth $1.35 Billion, making up 1.03% of all outstanding shares. On the other hand, Washington Mutual Investors Fund held roughly 20.45 Million shares worth around $1.03 Billion, which represents about 0.78% of the total shares outstanding.